人类癌症中dbc1表达的预后和临床病理学价值:系统性审查和元分析

Haojia Wang1,2,3,4,5,6,7,8, Xinhong Cheng1,9,10, Bruce Xianzhuo Zhang11

  • 1The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.

Frontiers in oncology
|July 22, 2025
PubMed
概括

癌症患者的高DBC1蛋白水平与较差的整体存活率和无复发存活率相关. 提升的DBC1表达也与晚期TNM阶段,远程转移和更高的组织学等级有关,表明其作为预后标记物的潜力.